| Please join us on Thursday, June 5th, at 5:00 pm ET (4:00 pm CT/2:00 pm PT) for a webinar about Healey ALS MyMatch, an innovative early phase, biomarker-driven clinical trial program launched in 2025. Sabrina Paganoni, MD, PhD of Mass General Hospital will be joined by guest speaker Suma Babu, MBBS, MPH to share information about ALS MyMatch and answer questions from the audience.
ALS MyMatch is a series of unique, custom-designed Phase 1b/2a clinical trials. The goal of the Healey ALS MyMatch program is to accelerate the path to new ALS therapies. Read the press release to learn more. |
